Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc. (TMCI) priced its initial public offering on Apr 26, 2021 at $17.00 per share, within its $15.00–$17.00 range, raising $191.2M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $857.9M. Latham & Watkins advised the company and Cooley advised the underwriters.

Treace Medical Concepts, Inc. is a commercial-stage orthopaedic medical device company focused on surgical treatment of bunions (Hallux Valgus). Its Lapiplasty 3D Bunion Correction System combines instruments, implants and surgical methods to correct the deformity in three dimensions.

Status

IPO

Ticker

TMCI

Exchange

Nasdaq Global Market

Priced

Apr 26, 2021

IPO price

$17.00

Price range

$15.00–$17.00

Raised

$191.2M

Market cap at IPO price

$857.9M

First filed

Mar 30, 2021

Company counsel

Latham & Watkins

Underwriters' counsel

Cooley

Sector

Healthcare

Country / state

FL

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.